We are live on
!
Find out more
FCMC
Founders Capital Management (Connecticut) Portfolio holdings
AUM
$670M
1-Year Est. Return
28.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.88%
1 Year Est. Return
+28.54%
3 Year Est. Return
+88.87%
5 Year Est. Return
+103.48%
10 Year Est. Return
+356.59%
AUM
$346M
AUM Growth
+$31.2M
(+9.9%)
Cap. Flow
-$1.33M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
59.58%
Holding
69
New
4
Increased
7
Reduced
28
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.49M |
| 2 |
Camden National
CAC
|
+$320K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$212K |
| 4 |
QVCGP
QVC Group Inc 8.0% Preferred Stock
QVCGP
|
+$132K |
| 5 |
Webster Financial
WBS
|
+$108K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo & Co Series Z Preferred Stock
WFC.PRZ
|
+$1.01M |
| 2 |
AT&T Series A
T.PRA
|
+$517K |
| 3 |
CarMax
KMX
|
+$428K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$331K |
| 5 |
Markel Group
MKL
|
+$287K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.01% |
| 2 | Communication Services | 17.59% |
| 3 | Technology | 16.32% |
| 4 | Financials | 14.66% |
| 5 | Consumer Discretionary | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Meta Platforms (Facebook)
META
$1.53T
| $467K | 0.13% |
1,710
| – | – |
|
|
WBA
52
DELISTED
Walgreens Boots Alliance
WBA
| $444K | 0.13% |
11,137
-2,400
| -18% | -$93K |
|
53
New York Times
NYT
$10.3B
| $414K | 0.12% |
8,000
| – | – |
|
54
Cigna
CI
$72.4B
| $389K | 0.11% |
1,870
| – | – |
|
55
Walmart Inc
WMT
$901B
| $354K | 0.1% |
7,365
| – | – |
|
56
Berkshire Hathaway Class A
BRK.A
$1.11T
| $348K | 0.1% |
1
| – | – |
|
|
57
Camden National
CAC
$982M
| $333K | 0.1% |
+9,300
| New | +$320K |
|
|
B
58
DELISTED
Barnes Group Inc.
B
| $305K | 0.09% |
6,016
| – | – |
|
59
Regeneron Pharmaceuticals
REGN
$82.1B
| $279K | 0.08% |
577
| – | – |
|
60
KeyCorp
KEY
$24.3B
| $276K | 0.08% |
16,800
| – | – |
|
61
Visa
V
$677B
| $274K | 0.08% |
1,253
| – | – |
|
62
Fastenal
FAST
$60.1B
| $249K | 0.07% |
10,200
| – | – |
|
|
63
Bristol-Myers Squibb
BMY
$130B
| $213K | 0.06% |
+3,440
| New | +$212K |
|
|
64
AT&T
T
$168B
| $213K | 0.06% |
9,821
| – | – |
|
65
Darden Restaurants
DRI
$25B
| $179K | 0.05% |
1,500
-1,500
| -50% | -$161K |
|
Similar funds
LCM
AGM
CHCM
TAP
CCM
GCIA
BCP
RCM
Founders Capital Management (Connecticut)'s Q4 2020 Portfolio in Review
As of Q4 2020, Founders Capital Management (Connecticut) held 69 positions worth $346M, up 9.9% from $315M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Founders Capital Management (Connecticut)'s Q4 2020 filing shows 4 new, 7 increased and 28 reduced positions. Its largest new stake was Merck: 32,524 shares worth $2.54M. The largest sale was Wells Fargo & Co Series Z Preferred Stock, an estimated $1.01M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Communication Services and Technology.
- Founders Capital Management (Connecticut)'s largest Q4 2020 buy was Merck: 32,524 shares worth $2.54M.
- Founders Capital Management (Connecticut) added most to QVC Group Inc 8.0% Preferred Stock in Q4 2020, an estimated $132K increase.
- Founders Capital Management (Connecticut)'s biggest Q4 2020 reduction was Wells Fargo & Co Series Z Preferred Stock, cutting an estimated $1.01M.
- Founders Capital Management (Connecticut)'s ten largest holdings make up 60% of its $346M portfolio in Q4 2020.
- Founders Capital Management (Connecticut) opened 4 new positions and closed 0 in Q4 2020.
- Founders Capital Management (Connecticut)'s portfolio value rose 9.9% quarter-over-quarter to $346M.
Based on Founders Capital Management (Connecticut)'s 13F filing for Q4 2020, filed 15 Jan 2021.